Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Other financing activities (2018 - 2024)

BioCorRx (BICX) has disclosed Other financing activities for 6 consecutive years, with $2584.0 as the latest value for Q1 2024.

  • Quarterly Other financing activities fell 91.07% to $2584.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $2584.0 through Dec 2024, changed N/A year-over-year, with the annual reading at $2584.0 for FY2024, N/A changed from the prior year.
  • Other financing activities hit $2584.0 in Q1 2024 for BioCorRx, up from -$28949.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $28949.0 in Q1 2023 to a low of -$28949.0 in Q2 2023.
  • Historically, Other financing activities has averaged -$4483.2 across 3 years, with a median of -$4750.0 in 2022.
  • Biggest YoY gain for Other financing activities was 91.07% in 2024; the steepest drop was 91.07% in 2024.
  • Year by year, Other financing activities stood at -$4750.0 in 2022, then plummeted by 509.45% to -$28949.0 in 2023, then soared by 108.93% to $2584.0 in 2024.
  • Business Quant data shows Other financing activities for BICX at $2584.0 in Q1 2024, -$28949.0 in Q2 2023, and $28949.0 in Q1 2023.